AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Aptech Ltd. Regulatory Filings 2023

Mar 10, 2023

60838_rns_2023-03-10_fc6354e4-ff65-4655-9f08-410a9bd7d25a.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Aptech Limited Regd. office: Aptech House A-65, MIDC, Moroi, Andheri (E), Mumbai - 400 093. T: 91 22 2827 2300 F: 91 22 2827 2399 www aptech-worldwide corn

==> picture [202 x 56] intentionally omitted <==

Unleash your potential

10[h] March 2023

To, BSE Limited 25[th] Floor, P J Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 532475

To, National Stock Exchange of India Limited Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051. Symbol: APTECHT

Dear Sir/Madam,

Sub: Intimation of schedule of Meeting with Investors / Analysts under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.

Pursuant to the provisions of Regulation 30 read with Regulation 46 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, our Company herewith intimates the schedule of a virtual meeting with Investor / Analyst on Friday, March 10, 2023 , at 5:00 PM (IST) with Compound 26 Capital . During the meeting, the management will comment on the Company’s business, financial results and operations for the quarter ended on December 31, 2022. The results and presentation to be discussed at the event have been uploaded on the website at:

- a) https://www.aptech worldwide.com/downloads/investorrelations_financials/Aptech Consolidated.pdf
- b) https://www.aptech worldwide.com/downloads/investorrelations_financials/Aptech Standalone.pdf
c) https://www.aptech - worldwide.com/downloads/investorPresentation/AptechLimitedQ3FY2022 23ResultsPresentation.pdf